|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/19 | |
| A61K 31/4152 |
| (11) | Patento numeris | 2434894 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10781176.2 |
| Europos patento paraiškos padavimo data | 2010-05-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/036294 |
| Data | 2010-05-27 |
| (87) | Numeris | WO 2010/138656 |
| Data | 2010-12-02 |
| (30) | Numeris | Data | Šalis |
| 182148 P | 2009-05-29 | US |
| (72) |
ERICKSON-MILLER, Connie, L., US
JENKINS, Julian, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | METHODS OF ADMINISTRATION OF THROMBOPOIETIN AGONIST COMPOUNDS |
| METHODS OF ADMINISTRATION OF THROMBOPOIETIN AGONIST COMPOUNDS |